236 related articles for article (PubMed ID: 32435279)
41. The effect of vitamin D supplementation on serum lipids in postmenopausal women with diabetes: A randomized controlled trial.
Muñoz-Aguirre P; Flores M; Macias N; Quezada AD; Denova-Gutiérrez E; Salmerón J
Clin Nutr; 2015 Oct; 34(5):799-804. PubMed ID: 25453396
[TBL] [Abstract][Full Text] [Related]
42. Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial.
Ranasinghe P; Wathurapatha WS; Galappatthy P; Katulanda P; Jayawardena R; Constantine GR
J Diabetes; 2018 May; 10(5):386-397. PubMed ID: 29072815
[TBL] [Abstract][Full Text] [Related]
43. The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled trial.
Taghizadeh M; Tamtaji OR; Dadgostar E; Daneshvar Kakhaki R; Bahmani F; Abolhassani J; Aarabi MH; Kouchaki E; Memarzadeh MR; Asemi Z
Neurochem Int; 2017 Sep; 108():183-189. PubMed ID: 28342967
[TBL] [Abstract][Full Text] [Related]
44. Vitamin D Supplementation Reduces Both Oxidative DNA Damage and Insulin Resistance in the Elderly with Metabolic Disorders.
Wenclewska S; Szymczak-Pajor I; Drzewoski J; Bunk M; Śliwińska A
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200560
[TBL] [Abstract][Full Text] [Related]
45. The effect of cardamom supplementation on serum lipids, glycemic indices and blood pressure in overweight and obese pre-diabetic women: a randomized controlled trial.
Fatemeh Y; Siassi F; Rahimi A; Koohdani F; Doostan F; Qorbani M; Sotoudeh G
J Diabetes Metab Disord; 2017; 16():40. PubMed ID: 29026804
[TBL] [Abstract][Full Text] [Related]
46. Omega-3 Fatty Acid Could Increase One of Myokines in Male Patients with Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
Agh F; Mohammadzadeh Honarvar N; Djalali M; Nematipour E; Gholamhoseini S; Zarei M; Ansari S; Javanbakht MH
Arch Iran Med; 2017 Jan; 20(1):28-33. PubMed ID: 28112528
[TBL] [Abstract][Full Text] [Related]
47. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
48. Effect of various doses of vitamin D supplementation on pregnant women with gestational diabetes mellitus: A randomized controlled trial.
Zhang Q; Cheng Y; He M; Li T; Ma Z; Cheng H
Exp Ther Med; 2016 Sep; 12(3):1889-1895. PubMed ID: 27588106
[TBL] [Abstract][Full Text] [Related]
49. Pre-Diabetics with Hypovitaminosis D Have Higher Risk for Insulin Resistance.
Nur-Eke R; Özen M; Çekin AH
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115227
[TBL] [Abstract][Full Text] [Related]
50. Vitamin A supplementation, serum lipids, liver enzymes and C-reactive protein concentrations in obese women of reproductive age.
Farhangi MA; Keshavarz SA; Eshraghian M; Ostadrahimi A; Saboor-Yaraghi AA
Ann Clin Biochem; 2013 Jan; 50(Pt 1):25-30. PubMed ID: 23148279
[TBL] [Abstract][Full Text] [Related]
51. The effect of different amounts of vitamin D supplementation on serum calcidiol, anthropometric status, and body composition in overweight or obese nursing women: a study protocol for a randomized placebo-controlled clinical trial.
Gerveieeha Z; Siassi F; Qorbani M; Ziaeian F; Sotoudeh G
Trials; 2019 Aug; 20(1):542. PubMed ID: 31470899
[TBL] [Abstract][Full Text] [Related]
52. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome.
Jamilian M; Samimi M; Mirhosseini N; Afshar Ebrahimi F; Aghadavod E; Talaee R; Jafarnejad S; Hashemi Dizaji S; Asemi Z
J Affect Disord; 2018 Oct; 238():32-38. PubMed ID: 29859385
[TBL] [Abstract][Full Text] [Related]
53. Metabolic and clinical responses to Bunium Persicum (black caraway) supplementation in overweight and obese patients with type 2 diabetes: a double-blind, randomized placebo-controlled clinical trial.
Jafari-Maskouni S; Shahraki M; Daneshi-Maskooni M; Dashipour A; Shamsi-Goushki A; Mortazavi Z
Nutr Metab (Lond); 2020; 17():74. PubMed ID: 32863846
[TBL] [Abstract][Full Text] [Related]
54. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
[TBL] [Abstract][Full Text] [Related]
55. Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial.
Salekzamani S; Mehralizadeh H; Ghezel A; Salekzamani Y; Jafarabadi MA; Bavil AS; Gargari BP
J Endocrinol Invest; 2016 Nov; 39(11):1303-1313. PubMed ID: 27400997
[TBL] [Abstract][Full Text] [Related]
56. Effect of vitamin D supplementation on serum lipid profiles: a systematic review and meta-analysis.
Dibaba DT
Nutr Rev; 2019 Dec; 77(12):890-902. PubMed ID: 31407792
[TBL] [Abstract][Full Text] [Related]
57. The benefits of ω-3 supplementation depend on adiponectin basal level and adiponectin increase after the supplementation: A randomized clinical trial.
Barbosa MM; Melo AL; Damasceno NR
Nutrition; 2017 Feb; 34():7-13. PubMed ID: 28063515
[TBL] [Abstract][Full Text] [Related]
58. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D.
Davidson MB; Duran P; Lee ML; Friedman TC
Diabetes Care; 2013 Feb; 36(2):260-6. PubMed ID: 23033239
[TBL] [Abstract][Full Text] [Related]
59. The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial.
Sohaei S; Amani R; Tarrahi MJ; Ghasemi-Tehrani H
Complement Ther Med; 2019 Dec; 47():102201. PubMed ID: 31780025
[TBL] [Abstract][Full Text] [Related]
60. The Effects of Omega-3 Fatty Acids Supplementation on Gene Expression Involved in the Insulin and Lipid Signaling Pathway in Patients with Polycystic Ovary Syndrome.
Nasri K; Hantoushzadeh S; Aghadavod E; Taghizadeh M; Asemi Z
Horm Metab Res; 2017 Jun; 49(6):446-451. PubMed ID: 28235206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
